DECISION OF THE EEA JOINT COMMITTEE No 102/2020

of 14 July 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1362]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2019/769 of 14 May 2019 amending Implementing Decision 2012/715/EU establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union  ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 15qb (Commission Implementing Decision 2012/715/EU) of Chapter XIII of Annex II to the EEA Agreement:

‘-

32019 D 0769: Commission Implementing Decision (EU) 2019/769 of 14 May 2019 ( OJ L 126, 15.5.2019, p. 70 ).’

Article 2

The text of Implementing Decision (EU) 2019/769 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 15 July 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made.  ( *1 )

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 14 July 2020.

For the EEA Joint Committee

The President

Sabine MONAUNI

( 1 )    OJ L 126, 15.5.2019, p. 70 .

( *1 )   No constitutional requirements indicated.